reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD008018-bib-0001,"Badawy A, Elnashar A, El-Ashry M, Shahat M. ",Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study, Fertility and Sterility ,2009,91,    ,['citation-journal']," Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.  Fertility and Sterility 2009;91:694-7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.fertnstert.2007.12.044', 'https://www.ncbi.nlm.nih.gov/pubmed/18675959', 'https://scholar.google.com/scholar_lookup?title=Gonadotropin-releasing+hormone+agonists+for+prevention+of+chemotherapy-induced+ovarian+damage:+prospective+randomized+study+&author=A+Badawy&author=A+Elnashar&author=M+El-Ashry&author=M+Shahat&publication_year=2009&hl=en']",18675959,https://doi.org/10.1016/j.fertnstert.2007.12.044, Badawy 2009 {published data only}  ,included,CD008018-bbs2-0001,
CD008018-bib-0002,"Elgindy EA, El-Haieg DO, Khorshid OM, Ismail EI, Abdelgawad M, Sallam HN, et al. ",Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial, Obsterics and Gynecology ,2013,121,    ,['citation-journal']," Elgindy EA, El-Haieg DO, Khorshid OM, Ismail EI, Abdelgawad M, Sallam HN, et al. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial.  Obsterics and Gynecology 2013;121(1):78-86. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/AOG.0b013e31827374e2', 'https://scholar.google.com/scholar_lookup?title=Gonadatrophin+suppression+to+prevent+chemotherapy-induced+ovarian+damage:+a+randomized+controlled+trial+&author=EA+Elgindy&author=DO+El-Haieg&author=OM+Khorshid&author=EI+Ismail&author=M+Abdelgawad&author=HN+Sallam&publication_year=2013&hl=en']",,https://doi.org/10.1097/AOG.0b013e31827374e2, Elgindy 2013 {published data only}  ,included,CD008018-bbs2-0002,
CD008018-bib-0003,"Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, et al. ",Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study, Journal of Clinical Oncology ,2011,29,    ,['citation-journal']," Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.  Journal of Clinical Oncology 2011;29(17):2334-41. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2010.32.5704', 'https://www.ncbi.nlm.nih.gov/pubmed/21537042', 'https://scholar.google.com/scholar_lookup?title=Effect+of+luteinizing+hormone-releasing+hormone+agonist+on+ovarian+function+after+modern+adjuvant+breast+cancer+chemotherapy:+the+GBG+37+ZORO+study+&author=B+Gerber&author=G+Minckwitz&author=H+Stehle&author=T+Reimer&author=R+Felberbaum&author=N+Maass&publication_year=2011&hl=en']",21537042,https://doi.org/10.1200/JCO.2010.32.5704, Gerber 2011 {published data only}  ,included,CD008018-bbs2-0003,
CD008018-bib-0004,"Gilani MM, Hasanzadeh M, Ghaemmaghami F, Ramazanzadeh F. ",Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy, Asia-Pacific Journal of Clinical Oncology ,2007,3,    ,['citation-journal']," Gilani MM, Hasanzadeh M, Ghaemmaghami F, Ramazanzadeh F. Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy.  Asia-Pacific Journal of Clinical Oncology 2007;3:79-83. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1111/j.1743-7563.2007.00089.x', 'https://scholar.google.com/scholar_lookup?title=Ovarian+preservation+with+gonadotropin-releasing+hormone+analog+during+chemotherapy&author=MM+Gilani&author=M+Hasanzadeh&author=F+Ghaemmaghami&author=F+Ramazanzadeh&publication_year=2007&hl=en']",,https://doi.org/10.1111/j.1743-7563.2007.00089.x, Gilani 2007 {published data only}  ,included,CD008018-bbs2-0004,
CD008018-bib-0005,"Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L. ",Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD), Hematology ,2007,12,    ,['citation-journal']," Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).  Hematology 2007;12:141-7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1080/10245330600954072', 'https://www.ncbi.nlm.nih.gov/pubmed/17454195', 'https://scholar.google.com/scholar_lookup?title=Ovarian+function+after+cancer+treatment+in+young+women+affected+by+Hodgkin+disease+(HD)+&author=L+Giuseppe&author=G+Attilio&author=DN+Edoardo&author=G+Loredana&author=L+Cristina&author=L+Vincenzo&publication_year=2007&hl=en']",17454195,https://doi.org/10.1080/10245330600954072, Giuseppe 2007 {published data only}  ,included,CD008018-bbs2-0005,
CD008018-bib-0006,"Karimi-Zarchi M, Forat-Yazdi M, Nakhaie-Moghadam M, Miratashi-Yazdi A, Teimoori S, Dehghani-Tafti A. ",Evaluation of fertility preservation with GnRH agonist in breast cancer cases treated with cyclophosphamide as a chemotherapy drug,,2017,,    ,['citation-other']," Karimi-Zarchi M, Forat-Yazdi M, Nakhaie-Moghadam M, Miratashi-Yazdi A, Teimoori S, Dehghani-Tafti A. Evaluation of fertility preservation with GnRH agonist in breast cancer cases treated with cyclophosphamide as a chemotherapy drug. In: International Journal of Reproductive Biomedicine. Vol. 4. 2017:Supplement 1. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+fertility+preservation+with+GnRH+agonist+in+breast+cancer+cases+treated+with+cyclophosphamide+as+a+chemotherapy+drug+&author=M+Karimi-Zarchi&author=M+Forat-Yazdi&author=M+Nakhaie-Moghadam&author=A+Miratashi-Yazdi&author=S+Teimoori&author=A+Dehghani-Tafti&publication_year=2017&hl=en']",,, Karimi‐Zarchi 2014 {published data only}  ,included,CD008018-bbs2-0006,
CD008018-bib-0007,"Karimi-Zarchi M, Forat-Yazdi M, Vafaeenasab MR, Nakhaie-Moghadam M, Miratashi-Yazdi A, Teimoori S, et al. ",Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide, European Journal of Gynaecological Oncology ,2014,35,    ,['citation-journal']," Karimi-Zarchi M, Forat-Yazdi M, Vafaeenasab MR, Nakhaie-Moghadam M, Miratashi-Yazdi A, Teimoori S, et al. Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide.  European Journal of Gynaecological Oncology 2014;35(1):59-61. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/24654464', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+the+effect+of+GnRH+agonist+on+menstrual+reverse+in+breast+cancer+cases+treated+with+cyclophosphamide+&author=M+Karimi-Zarchi&author=M+Forat-Yazdi&author=MR+Vafaeenasab&author=M+Nakhaie-Moghadam&author=A+Miratashi-Yazdi&author=S+Teimoori&publication_year=2014&hl=en']",24654464,, Karimi‐Zarchi 2014 {published data only}  ,included,CD008018-bbs2-0006,
CD008018-bib-0008,"Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, et al. ",Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial, Journal of the American Medical Association ,2011,306,    ,['citation-journal']," Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.  Journal of the American Medical Association 2011;306(3):269-76. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/21771987', 'https://scholar.google.com/scholar_lookup?title=Effect+of+the+gonadotropin-releasing+hormone+analogue+triptorelin+on+the+occurrence+of+chemotherapy-induced+early+menopause+in+premenopausal+women+with+breast+cancer:+a+randomized+trial+&author=L+DelMastro&author=L+Boni&author=A+Michelotti&author=T+Gamucci&author=N+Olmeo&author=S+Gori&publication_year=2011&hl=en']",21771987,, Lambertini 2015a {published data only}  ,included,CD008018-bbs2-0007,
CD008018-bib-0009,"Lambertini M, Boni L, Michelotti A, Gamucci T, Scotto T, Gori S, et al. ","Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial", Journal of the American Medical Association ,2015,314,    ,['citation-journal']," Lambertini M, Boni L, Michelotti A, Gamucci T, Scotto T, Gori S, et al. Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial.  Journal of the American Medical Association 2015;314(24):2632-40. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/jama.2015.17291', 'https://www.ncbi.nlm.nih.gov/pubmed/26720025', 'https://scholar.google.com/scholar_lookup?title=Ovarian+suppression+with+triptorelin+during+adjuvant+breast+cancer+chemotherapy+and+long-term+ovarian+function,+pregnancies,+and+disease-free+survival:+a+randomized+clinical+trial+&author=M+Lambertini&author=L+Boni&author=A+Michelotti&author=T+Gamucci&author=T+Scotto&author=S+Gori&publication_year=2015&hl=en']",26720025,https://doi.org/10.1001/jama.2015.17291, Lambertini 2015a {published data only}  ,included,CD008018-bbs2-0007,
CD008018-bib-0010,"Leonard RC, Adamson DJ, Bertelli G, Mansi J, Yellowlees A, Dunlop J, et al. ",GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial, Annals of Oncology ,2017,28,    ,['citation-journal']," Leonard RC, Adamson DJ, Bertelli G, Mansi J, Yellowlees A, Dunlop J, et al. GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial.  Annals of Oncology 2017;28:1811-6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/annonc/mdx184', 'https://www.ncbi.nlm.nih.gov/pubmed/28472240', 'https://scholar.google.com/scholar_lookup?title=GnRH+agonist+for+protection+against+ovarian+toxicity+during+chemotherapy+for+early+breast+cancer:+the+Anglo+Celtic+Group+OPTION+trial+&author=RC+Leonard&author=DJ+Adamson&author=G+Bertelli&author=J+Mansi&author=A+Yellowlees&author=J+Dunlop&publication_year=2017&hl=en']",28472240,https://doi.org/10.1093/annonc/mdx184, Leonard 2017 {published data only}  ,included,CD008018-bbs2-0008,
CD008018-bib-0011,"Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, et al. ",Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy, New England Journal of Medicine ,2015,372,    ,['citation-journal']," Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.  New England Journal of Medicine 2015;372(10):923-32. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa1413204', 'https://www.ncbi.nlm.nih.gov/pubmed/25738668', 'https://scholar.google.com/scholar_lookup?title=Goserelin+for+ovarian+protection+during+breast-cancer+adjuvant+chemotherapy&author=HC+Moore&author=JM+Unger&author=KA+Phillips&author=F+Boyle&author=E+Hitre&author=D+Porter&publication_year=2015&hl=en']",25738668,https://doi.org/10.1056/NEJMoa1413204, Moore 2015 {published data only}  ,included,CD008018-bbs2-0009,
CD008018-bib-0012,"Munster PN, Moore AP, Ismailkhan R, Cox CE, Lacevic M, Gross-King M, et al. ",Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer, Journal of Clinical Oncology ,2012,30,    ,['citation-journal']," Munster PN, Moore AP, Ismailkhan R, Cox CE, Lacevic M, Gross-King M, et al. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.  Journal of Clinical Oncology 2012;30(5):533-8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2011.34.6890', 'https://www.ncbi.nlm.nih.gov/pubmed/22231041', 'https://scholar.google.com/scholar_lookup?title=Randomized+trial+using+gonadotropin-releasing+hormone+agonist+triptorelin+for+the+preservation+of+ovarian+function+during+(neo)adjuvant+chemotherapy+for+breast+cancer+&author=PN+Munster&author=AP+Moore&author=R+Ismailkhan&author=CE+Cox&author=M+Lacevic&author=M+Gross-King&publication_year=2012&hl=en']",22231041,https://doi.org/10.1200/JCO.2011.34.6890, Munster 2012 {published data only}  ,included,CD008018-bbs2-0010,
CD008018-bib-0013,"Song G, Gao H, Yuan Z. ",Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial," Medical Oncology (Northwood, London, England) ",2013,30,    ,['citation-journal']," Song G, Gao H, Yuan Z. Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.  Medical Oncology (Northwood, London, England) 2013;30(3):667. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s12032-013-0667-8', 'https://www.ncbi.nlm.nih.gov/pubmed/23904400', 'https://scholar.google.com/scholar_lookup?title=Effect+of+leuprolide+acetate+on+ovarian+function+after+cyclophosphamide-doxorubicin-based+chemotherapy+in+premenopausal+patients+with+breast+cancer:+results+from+a+phase+II+randomized+trial+&author=G+Song&author=H+Gao&author=Z+Yuan&publication_year=2013&hl=en']",23904400,https://doi.org/10.1007/s12032-013-0667-8, Song 2013 {published data only}  ,included,CD008018-bbs2-0011,
CD008018-bib-0014,"Waxman JH, Ahmed R, Smith D, Wrigley PF, Gregory W, Shalet S, et al. ",Failure to preserve fertility in patients with Hodgkin's disease, Cancer Chemotherapy and Pharmacology ,1987,19,    ,['citation-journal']," Waxman JH, Ahmed R, Smith D, Wrigley PF, Gregory W, Shalet S, et al. Failure to preserve fertility in patients with Hodgkin's disease.  Cancer Chemotherapy and Pharmacology 1987;19:159-62. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/BF00254570', 'https://www.ncbi.nlm.nih.gov/pubmed/3105906', ""https://scholar.google.com/scholar_lookup?title=Failure+to+preserve+fertility+in+patients+with+Hodgkin's+disease&author=JH+Waxman&author=R+Ahmed&author=D+Smith&author=PF+Wrigley&author=W+Gregory&author=S+Shalet&publication_year=1987&hl=en""]",3105906,https://doi.org/10.1007/BF00254570, Waxman 1987 {published data only}  ,included,CD008018-bbs2-0012,
CD008018-bib-0015,"Bernhard J, Zahrieh D, Castiglione-Gertsch M, Hurny C, Gelber RD, Forbes JF, et al. ","Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients- the International Breast Cancer Study Group trial VIII", Journal of Clinical Oncology ,2007,25,    ,['citation-journal']," Bernhard J, Zahrieh D, Castiglione-Gertsch M, Hurny C, Gelber RD, Forbes JF, et al. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients- the International Breast Cancer Study Group trial VIII.  Journal of Clinical Oncology 2007;25:263-70. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2005.04.5393', 'https://www.ncbi.nlm.nih.gov/pubmed/17159194', 'https://scholar.google.com/scholar_lookup?title=Adjuvant+chemotherapy+followed+by+goserelin+compared+with+either+modality+alone:+the+impact+on+amenorrhea,+hot+flashes,+and+quality+of+life+in+premenopausal+patients-+the+International+Breast+Cancer+Study+Group+trial+VIII+&author=J+Bernhard&author=D+Zahrieh&author=M+Castiglione-Gertsch&author=C+Hurny&author=RD+Gelber&author=JF+Forbes&publication_year=2007&hl=en']",17159194,https://doi.org/10.1200/JCO.2005.04.5393, Bernhard 2007 {published data only}  ,excluded,CD008018-bbs2-0013, Not intervention of interest 
CD008018-bib-0016,"Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, et al. ",No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial, Journal of Clinical Oncology ,2016,34,    ,['citation-journal']," Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, et al. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial.  Journal of Clinical Oncology 2016;34(22):2568-74. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1200/JCO.2015.65.8864', 'https://www.ncbi.nlm.nih.gov/pubmed/27217453', 'https://scholar.google.com/scholar_lookup?title=No+evidence+for+the+benefit+of+gonadotropin-releasing+hormone+agonist+in+preserving+ovarian+function+and+fertility+in+lymphoma+survivors+treated+with+chemotherapy:+final+long-term+report+of+a+prospective+randomized+trial+&author=I+Demeestere&author=P+Brice&author=FA+Peccatori&author=A+Kentos&author=J+Dupuis&author=P+Zachee&publication_year=2016&hl=en']",27217453,https://doi.org/10.1200/JCO.2015.65.8864, Demeestere 2016 {published data only}  ,excluded,CD008018-bbs2-0014, Wrong population 
CD008018-bib-0017,"Mina R, Reiff A, Silva CA, Fernandez PV, Higgins GC, Imundo LF, et al. ",Phase 2 trial on triptorelin for ovary protection in childhood-onset systemic lupus erythematosus,,2013,,    ,['citation-other']," Mina R, Reiff A, Silva CA, Fernandez PV, Higgins GC, Imundo LF, et al. Phase 2 trial on triptorelin for ovary protection in childhood-onset systemic lupus erythematosus. In: ACR/ARHP Annual Meeting. 2013. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Phase+2+trial+on+triptorelin+for+ovary+protection+in+childhood-onset+systemic+lupus+erythematosus+&author=R+Mina&author=A+Reiff&author=CA+Silva&author=PV+Fernandez&author=GC+Higgins&author=LF+Imundo&publication_year=2013&hl=en']",,, Mina 2013 {published data only}  ,excluded,CD008018-bbs2-0015, Not outcome of interest 
CD008018-bib-0018,"Regan MM, Walley BA, Francis PA, Fleming GF, Láng I, Gómez HL, et al. ",Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT, Annals of Oncology ,2017,28,    ,['citation-journal']," Regan MM, Walley BA, Francis PA, Fleming GF, Láng I, Gómez HL, et al. Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.  Annals of Oncology 2017;28:2225-32. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/annonc/mdx285', 'https://www.ncbi.nlm.nih.gov/pubmed/28911092', 'https://scholar.google.com/scholar_lookup?title=Concurrent+and+sequential+initiation+of+ovarian+function+suppression+with+chemotherapy+in+premenopausal+women+with+endocrine-responsive+early+breast+cancer:+an+exploratory+analysis+of+TEXT+and+SOFT+&author=MM+Regan&author=BA+Walley&author=PA+Francis&author=GF+Fleming&author=I+Láng&author=HL+Gómez&publication_year=2017&hl=en']",28911092,https://doi.org/10.1093/annonc/mdx285, Regan 2017 {published data only}  ,excluded,CD008018-bbs2-0016, Not intervention of interest 
CD008018-bib-0019,"Sverrisdottir A, Nystedt M, Johansson H, Fornander T. ",Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial, Breast Cancer Research and Treatment ,2009,117,    ,['citation-journal']," Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.  Breast Cancer Research and Treatment 2009;117(3):561-7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s10549-009-0313-5', 'https://www.ncbi.nlm.nih.gov/pubmed/19153828', 'https://scholar.google.com/scholar_lookup?title=Adjuvant+goserelin+and+ovarian+preservation+in+chemotherapy+treated+patients+with+early+breast+cancer:+results+from+a+randomized+trial+&author=A+Sverrisdottir&author=M+Nystedt&author=H+Johansson&author=T+Fornander&publication_year=2009&hl=en']",19153828,https://doi.org/10.1007/s10549-009-0313-5, Sverrisdottir 2009 {published data only}  ,excluded,CD008018-bbs2-0017, Wrong population 
CD008018-bib-0020,"Zhang Y, Ji Y, Li J, Lei L, Wu S, Zuo W, et al. ","Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival", Breast Cancer Research and Treatment ,2018,168,    ,['citation-journal']," Zhang Y, Ji Y, Li J, Lei L, Wu S, Zuo W, et al. Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival.  Breast Cancer Research and Treatment 2018;168(3):1-8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s10549-018-4660-y', 'https://www.ncbi.nlm.nih.gov/pubmed/29214416', 'https://scholar.google.com/scholar_lookup?title=Sequential+versus+simultaneous+use+of+chemotherapy+and+gonadotropin-releasing+hormone+agonist+(GnRHa)+among+estrogen+receptor+(ER)-positive+premenopausal+breast+cancer+patients:+effects+on+ovarian+function,+disease-free+survival,+and+overall+survival+&author=Y+Zhang&author=Y+Ji&author=J+Li&author=L+Lei&author=S+Wu&author=W+Zuo&publication_year=2018&hl=en']",29214416,https://doi.org/10.1007/s10549-018-4660-y, Zhang 2018 {published data only}  ,excluded,CD008018-bbs2-0018, Wrong population 
CD008018-bib-0032,,AGO clinical practice guidelines in oncology,,,,. www.ago-online.de/en/guidelines-mamma/april-2017 Data accessed in October 2018.   ,['citation-other'], AGO clinical practice guidelines in oncology. www.ago-online.de/en/guidelines-mamma/april-2017 Data accessed in October 2018.    ,[],,, AGO 2017 ,additional,CD008018-bbs2-0030,
CD008018-bib-0033,Ahmed Badawy. ,Additional data [personal communication],,,,. Email to: Ahmed Badawy 16 September 2018.   ,['citation-other'], Ahmed Badawy. Additional data [personal communication]. Email to: Ahmed Badawy 16 September 2018.    ,[],,, Badawy 2009 [pers comm] ,additional,CD008018-bbs2-0031,
CD008018-bib-0034,"Bedoschi G, Navarro PA, Oktay K. ",Chemotherapy-induced damage to ovary: mechanisms and clinical impact, Future Oncology ,2016,12,    ,['citation-journal']," Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.  Future Oncology 2016;12(20):2333-44.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.2217/fon-2016-0176', 'https://www.ncbi.nlm.nih.gov/pubmed/27402553', 'https://scholar.google.com/scholar_lookup?title=Chemotherapy-induced+damage+to+ovary:+mechanisms+and+clinical+impact&author=G+Bedoschi&author=PA+Navarro&author=K+Oktay&publication_year=2016&hl=en']",27402553,https://doi.org/10.2217/fon-2016-0176, Bedoschi 2016 ,additional,CD008018-bbs2-0032,
CD008018-bib-0035,"Blumenfeld Z, Avivi I, Ritter M, Rowe JM. ",Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women, Journal of the Society for Gynecologic Investigation ,1999,6,    ,['citation-journal']," Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.  Journal of the Society for Gynecologic Investigation 1999;6:229-39.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1177/107155769900600502', 'https://www.ncbi.nlm.nih.gov/pubmed/10554760', 'https://scholar.google.com/scholar_lookup?title=Preservation+of+fertility+and+ovarian+function+and+minimizing+chemotherapy-induced+gonadotoxicity+in+young+women+&author=Z+Blumenfeld&author=I+Avivi&author=M+Ritter&author=JM+Rowe&publication_year=1999&hl=en']",10554760,https://doi.org/10.1177/107155769900600502, Blumenfeld 1999 ,additional,CD008018-bbs2-0033,
CD008018-bib-0036,Blumenfeld Z. ,"How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist co-treatment in addition to cryopreservation of embrya, oocytes, or ovaries", The Oncologist ,2007,12,    ,['citation-journal']," Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist co-treatment in addition to cryopreservation of embrya, oocytes, or ovaries.  The Oncologist 2007;12:1044-54.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1634/theoncologist.12-9-1044', 'https://www.ncbi.nlm.nih.gov/pubmed/17914074', 'https://scholar.google.com/scholar_lookup?title=How+to+preserve+fertility+in+young+women+exposed+to+chemotherapy?+The+role+of+GnRH+agonist+co-treatment+in+addition+to+cryopreservation+of+embrya,+oocytes,+or+ovaries+&author=Z+Blumenfeld&publication_year=2007&hl=en']",17914074,https://doi.org/10.1634/theoncologist.12-9-1044, Blumenfeld 2007 ,additional,CD008018-bbs2-0034,
CD008018-bib-0037,"Blumenfeld Z, Von Wolff M. ",GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy, Human Reproduction Update ,2008,14,    ,['citation-journal']," Blumenfeld Z, Von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.  Human Reproduction Update 2008;14:543-52.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humupd/dmn022', 'https://www.ncbi.nlm.nih.gov/pubmed/18824495', 'https://scholar.google.com/scholar_lookup?title=GnRH-analogues+and+oral+contraceptives+for+fertility+preservation+in+women+during+chemotherapy+&author=Z+Blumenfeld&author=M+VonWolff&publication_year=2008&hl=en']",18824495,https://doi.org/10.1093/humupd/dmn022, Blumenfeld 2008b ,additional,CD008018-bbs2-0035,
CD008018-bib-0038,"D'avila AM, Biolchi V, Capp E, Corleta H. ","Age, anti-mullerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide", Journal of Ovarian Research ,2015,8,    ,['citation-journal']," D'avila AM, Biolchi V, Capp E, Corleta H. Age, anti-mullerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide.  Journal of Ovarian Research 2015;8(1):82.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1186/s13048-015-0209-4', 'https://www.ncbi.nlm.nih.gov/pubmed/26667243', ""https://scholar.google.com/scholar_lookup?title=Age,+anti-mullerian+hormone,+antral+follicles+count+to+predict+amenorrhea+or+oligomenorrhea+after+chemotherapy+with+cyclophosphamide+&author=AM+D'avila&author=V+Biolchi&author=E+Capp&author=H+Corleta&publication_year=2015&hl=en""]",26667243,https://doi.org/10.1186/s13048-015-0209-4, D'avila 2015 ,additional,CD008018-bbs2-0036,
CD008018-bib-0039,"Danforth DR, Arbogast LK, Friedman CI. ",Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists, Fertility and Sterility ,2005,83,    ,['citation-journal']," Danforth DR, Arbogast LK, Friedman CI. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists.  Fertility and Sterility 2005;83:1333-8.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.fertnstert.2004.12.030', 'https://www.ncbi.nlm.nih.gov/pubmed/15866565', 'https://scholar.google.com/scholar_lookup?title=Acute+depletion+of+murine+primordial+follicle+reserve+by+gonadotropin-releasing+hormone+antagonists+&author=DR+Danforth&author=LK+Arbogast&author=CI+Friedman&publication_year=2005&hl=en']",15866565,https://doi.org/10.1016/j.fertnstert.2004.12.030, Danforth 2005 ,additional,CD008018-bbs2-0037,
CD008018-bib-0040,"Dayangan Sayan C, Tulmac OB, Karaca G, Ozkan ZS, Yalcin S, Devrim T, et al. ",Could erythropoietin reduce the ovarian damage of cisplatin in female rats, Gynecological Endocrinology ,2018,34,    ,['citation-journal']," Dayangan Sayan C, Tulmac OB, Karaca G, Ozkan ZS, Yalcin S, Devrim T, et al. Could erythropoietin reduce the ovarian damage of cisplatin in female rats.  Gynecological Endocrinology 2018;34(4):309-13.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1080/09513590.2017.1395836', 'https://www.ncbi.nlm.nih.gov/pubmed/29084473', 'https://scholar.google.com/scholar_lookup?title=Could+erythropoietin+reduce+the+ovarian+damage+of+cisplatin+in+female+rats&author=C+DayanganSayan&author=OB+Tulmac&author=G+Karaca&author=ZS+Ozkan&author=S+Yalcin&author=T+Devrim&publication_year=2018&hl=en']",29084473,https://doi.org/10.1080/09513590.2017.1395836, Dayangan Sayan 2018 ,additional,CD008018-bbs2-0038,
CD008018-bib-0041,"Deeks JJ, Higgins JP, Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. ","Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017",,,,. Available from www.training.cochrane.org/handbook Data accessed in October 2018.   ,['citation-other']," Deeks JJ, Higgins JP, Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook Data accessed in October 2018.    ",[],,, Deeks 2017 ,additional,CD008018-bbs2-0039,
CD008018-bib-0042,"De Koning CH, Popp-Snijders C, Schoemaker J, Lambalk CB. ",Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH, Human Reproduction ,2000,15,    ,['citation-journal']," De Koning CH, Popp-Snijders C, Schoemaker J, Lambalk CB. Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH.  Human Reproduction 2000;15(7):1452-6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humrep/15.7.1452', 'https://www.ncbi.nlm.nih.gov/pubmed/10875849', 'https://scholar.google.com/scholar_lookup?title=Elevated+FSH+concentrations+in+imminent+ovarian+failure+are+associated+with+higher+FSH+and+LH+pulse+amplitude+and+response+to+GnRH+&author=CH+DeKoning&author=C+Popp-Snijders&author=J+Schoemaker&author=CB+Lambalk&publication_year=2000&hl=en']",10875849,https://doi.org/10.1093/humrep/15.7.1452, De Koning 2000 ,additional,CD008018-bbs2-0040,
CD008018-bib-0043,Eman A Elgindy. ,Additional or missing data [personal communication],,,,. Email to: Eman A. Elgindy 15 September 2018.   ,['citation-other'], Eman A Elgindy. Additional or missing data [personal communication]. Email to: Eman A. Elgindy 15 September 2018.    ,[],,, Elgindy 2013 [pers comm] ,additional,CD008018-bbs2-0041,
CD008018-bib-0044,"Falcone T, Bedaiwy MA. ",Fertility preservation and pregnancy outcome after malignancy, Current Opinion in Obstetrics and Gynecology ,2005,17,    ,['citation-journal']," Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy.  Current Opinion in Obstetrics and Gynecology 2005;17:21-6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/00001703-200502000-00005', 'https://www.ncbi.nlm.nih.gov/pubmed/15711407', 'https://scholar.google.com/scholar_lookup?title=Fertility+preservation+and+pregnancy+outcome+after+malignancy&author=T+Falcone&author=MA+Bedaiwy&publication_year=2005&hl=en']",15711407,https://doi.org/10.1097/00001703-200502000-00005, Falcone 2005 ,additional,CD008018-bbs2-0042,
CD008018-bib-0045,Sibylle Loibl. ,Additional data [personal communication],,,,. Email to: Sibylle Loibl 15 September 2018.   ,['citation-other'], Sibylle Loibl. Additional data [personal communication]. Email to: Sibylle Loibl 15 September 2018.    ,[],,, Gerber 2011 [pers comm] ,additional,CD008018-bbs2-0043,
CD008018-bib-0046,Loverro Giuseppe. ,Additional or missing data [personal communication],,,,. Email to: Loverro Giuseppe 16 April 2018.   ,['citation-other'], Loverro Giuseppe. Additional or missing data [personal communication]. Email to: Loverro Giuseppe 16 April 2018.    ,[],,, Giuseppe 2007 [pers comm] ,additional,CD008018-bbs2-0044,
CD008018-bib-0047,"Guenther V, Alkatout I, Junkers W, Bauerschlag D, Maass N, von Otte S. ",Fertility preservation in female patients with breast cancer - a current overview, Geburtshilfe Frauenheilkd ,2017,77,    ,['citation-journal']," Guenther V, Alkatout I, Junkers W, Bauerschlag D, Maass N, von Otte S. Fertility preservation in female patients with breast cancer - a current overview.  Geburtshilfe Frauenheilkd 2017;77(10):1088-94.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1055/s-0043-119543', 'https://www.ncbi.nlm.nih.gov/pubmed/29093602', 'https://scholar.google.com/scholar_lookup?title=Fertility+preservation+in+female+patients+with+breast+cancer+-+a+current+overview&author=V+Guenther&author=I+Alkatout&author=W+Junkers&author=D+Bauerschlag&author=N+Maass&author=S+Otte&publication_year=2017&hl=en']",29093602,https://doi.org/10.1055/s-0043-119543, Guenther 2017 ,additional,CD008018-bbs2-0045,
CD008018-bib-0048,"Hasky N, Uri-Belapolsky S, Goldberg K, Miller I, Grossman H, Stemmer SM, et al. ",Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?, Human Reproduction ,2015,30,    ,['citation-journal']," Hasky N, Uri-Belapolsky S, Goldberg K, Miller I, Grossman H, Stemmer SM, et al. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma? Human Reproduction 2015;30(5):1089-101.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humrep/dev037', 'https://www.ncbi.nlm.nih.gov/pubmed/25796551', 'https://scholar.google.com/scholar_lookup?title=Gonadotrophin-releasing+hormone+agonists+for+fertility+preservation:+unraveling+the+enigma?+&author=N+Hasky&author=S+Uri-Belapolsky&author=K+Goldberg&author=I+Miller&author=H+Grossman&author=SM+Stemmer&publication_year=2015&hl=en']",25796551,https://doi.org/10.1093/humrep/dev037, Hasky 2015 ,additional,CD008018-bbs2-0046,
CD008018-bib-0049,"Hickman LC, Llarena NC, Valentine LN, Liu X, Falcone T. ",Preservation of gonadal function in women undergoing chemotherapy a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists, Journal of Assisted Reproduction and Genetics ,2018,35,    ,['citation-journal']," Hickman LC, Llarena NC, Valentine LN, Liu X, Falcone T. Preservation of gonadal function in women undergoing chemotherapy a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.  Journal of Assisted Reproduction and Genetics 2018;35(4):571-81.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s10815-018-1128-2', 'https://www.ncbi.nlm.nih.gov/pubmed/29470701', 'https://scholar.google.com/scholar_lookup?title=Preservation+of+gonadal+function+in+women+undergoing+chemotherapy+a+systematic+review+and+meta-analysis+of+the+potential+role+for+gonadotropin-releasing+hormone+agonists+&author=LC+Hickman&author=NC+Llarena&author=LN+Valentine&author=X+Liu&author=T+Falcone&publication_year=2018&hl=en']",29470701,https://doi.org/10.1007/s10815-018-1128-2, Hickman 2018 ,additional,CD008018-bbs2-0047,
CD008018-bib-0050,"Higgins JP, Thompson SG, Deeks JJ, Altman DG. ",Measuring inconsistency in meta-analyses, BMJ ,2003,327,    ,['citation-journal']," Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses.  BMJ 2003;327:557-60.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.327.7414.557', 'https://www.ncbi.nlm.nih.gov/pubmed/12958120', 'https://scholar.google.com/scholar_lookup?title=Measuring+inconsistency+in+meta-analyses&author=JP+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en']",12958120,https://doi.org/10.1136/bmj.327.7414.557, Higgins 2003 ,additional,CD008018-bbs2-0048,
CD008018-bib-0051,"Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. ",The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ ,2011,343,    ,['citation-journal']," Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.  BMJ 2011;343:d5928.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.d5928', 'https://www.ncbi.nlm.nih.gov/pubmed/22008217', ""https://scholar.google.com/scholar_lookup?title=The+Cochrane+Collaboration's+tool+for+assessing+risk+of+bias+in+randomised+trials&author=JP+Higgins&author=DG+Altman&author=PC+Gøtzsche&author=P+Jüni&author=D+Moher&author=AD+Oxman&publication_year=2011&hl=en""]",22008217,https://doi.org/10.1136/bmj.d5928, Higgins 2011a ,additional,CD008018-bbs2-0049,
CD008018-bib-0052,"Higgins JP, Green S (editors). ","Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from www.handbook.cochrane.org Data accessed in September 2018.   ,['citation-other']," Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org Data accessed in September 2018.    ",[],,, Higgins 2011b ,additional,CD008018-bbs2-0050,
CD008018-bib-0053,"Higgins JP, Altman DG, Sterne JA (editors). ","Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017",,,,. Available from www.training.cochrane.org/handbook Data accessed in September 2018.   ,['citation-other']," Higgins JP, Altman DG, Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook Data accessed in September 2018.    ",[],,, Higgins 2017 ,additional,CD008018-bbs2-0051,
CD008018-bib-0054,"Horicks F, Van Den Steen G, Houben S, Englert Y, Demeestere I. ",Folliculogenesis is not fully inhibited during GnRH analogues treatment in mice challenging their efficiency to preserve the ovarian reserve during chemotherapy in this model, PLoS One ,2015,10,    ,['citation-journal']," Horicks F, Van Den Steen G, Houben S, Englert Y, Demeestere I. Folliculogenesis is not fully inhibited during GnRH analogues treatment in mice challenging their efficiency to preserve the ovarian reserve during chemotherapy in this model.  PLoS One 2015;10(9):e0137164.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1371/journal.pone.0137164', 'https://www.ncbi.nlm.nih.gov/pubmed/26325271', 'https://scholar.google.com/scholar_lookup?title=Folliculogenesis+is+not+fully+inhibited+during+GnRH+analogues+treatment+in+mice+challenging+their+efficiency+to+preserve+the+ovarian+reserve+during+chemotherapy+in+this+model+&author=F+Horicks&author=G+VanDenSteen&author=S+Houben&author=Y+Englert&author=I+Demeestere&publication_year=2015&hl=en']",26325271,https://doi.org/10.1371/journal.pone.0137164, Horicks 2015 ,additional,CD008018-bbs2-0052,
CD008018-bib-0055,"Horicks F, Van Den Steen G, Gervy C, Clarke HJ, Demeestere I. ",Both in vivo FSH depletion and follicular exposure to gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice, Molecular Human Reproduction ,2018,24,    ,['citation-journal']," Horicks F, Van Den Steen G, Gervy C, Clarke HJ, Demeestere I. Both in vivo FSH depletion and follicular exposure to gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.  Molecular Human Reproduction 2018;24(4):221-32.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/molehr/gay005', 'https://www.ncbi.nlm.nih.gov/pubmed/29438534', 'https://scholar.google.com/scholar_lookup?title=Both+in+vivo+FSH+depletion+and+follicular+exposure+to+gonadotrophin-releasing+hormone+analogues+in+vitro+are+not+effective+to+prevent+follicular+depletion+during+chemotherapy+in+mice+&author=F+Horicks&author=G+VanDenSteen&author=C+Gervy&author=HJ+Clarke&author=I+Demeestere&publication_year=2018&hl=en']",29438534,https://doi.org/10.1093/molehr/gay005, Horicks 2018 ,additional,CD008018-bbs2-0053,
CD008018-bib-0056,"Huang YH, Zhao XJ, Zhang QH, Xin XY. ",The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis, Gynecologic Oncology ,2009,112,    ,['citation-journal']," Huang YH, Zhao XJ, Zhang QH, Xin XY. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.  Gynecologic Oncology 2009;112(2):409-14.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ygyno.2008.09.044', 'https://www.ncbi.nlm.nih.gov/pubmed/19038435', 'https://scholar.google.com/scholar_lookup?title=The+GnRH+antagonist+reduces+chemotherapy-induced+ovarian+damage+in+rats+by+suppressing+the+apoptosis+&author=YH+Huang&author=XJ+Zhao&author=QH+Zhang&author=XY+Xin&publication_year=2009&hl=en']",19038435,https://doi.org/10.1016/j.ygyno.2008.09.044, Huang 2009 ,additional,CD008018-bbs2-0054,
CD008018-bib-0057,"Imai A, Sugiyama M, Furui T, Tamaya T, Ohno T. ",Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage, Gynecologic and Obstetric Investigation ,2007,63,    ,['citation-journal']," Imai A, Sugiyama M, Furui T, Tamaya T, Ohno T. Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage.  Gynecologic and Obstetric Investigation 2007;63:102-6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1159/000096062', 'https://www.ncbi.nlm.nih.gov/pubmed/17028438', 'https://scholar.google.com/scholar_lookup?title=Direct+protection+by+a+gonadotropin-releasing+hormone+analog+from+doxorubicin-induced+granulosa+cell+damage+&author=A+Imai&author=M+Sugiyama&author=T+Furui&author=T+Tamaya&author=T+Ohno&publication_year=2007&hl=en']",17028438,https://doi.org/10.1159/000096062, Imai 2007 ,additional,CD008018-bbs2-0055,
CD008018-bib-0058,"Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. ","Cyclophosphamide triggers follicle activation and ""burnout""; AS101 prevents follicle loss and preserves fertility", Science Translational Medicine ,2013,5,    ,['citation-journal']," Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and ""burnout""; AS101 prevents follicle loss and preserves fertility.  Science Translational Medicine 2013;5(185):185ra62.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1126/scitranslmed.3005402', 'https://www.ncbi.nlm.nih.gov/pubmed/23677591', 'https://scholar.google.com/scholar_lookup?title=Cyclophosphamide+triggers+follicle+activation+and+']",23677591,https://doi.org/10.1126/scitranslmed.3005402, Kalich‐Philosoph 2013 ,additional,CD008018-bbs2-0056,
CD008018-bib-0059,"Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, et al. ",AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy, Proceedings of the National Academy of Sciences of the United States of America ,2017,114,    ,['citation-journal']," Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, et al. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy.  Proceedings of the National Academy of Sciences of the United States of America 2017;114(9):E1688-97.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1073/pnas.1620729114', 'https://www.ncbi.nlm.nih.gov/pubmed/28137855', 'https://scholar.google.com/scholar_lookup?title=AMH/MIS+as+a+contraceptive+that+protects+the+ovarian+reserve+during+chemotherapy&author=M+Kano&author=AE+Sosulski&author=L+Zhang&author=HD+Saatcioglu&author=D+Wang&author=N+Nagykery&publication_year=2017&hl=en']",28137855,https://doi.org/10.1073/pnas.1620729114, Kano 2017 ,additional,CD008018-bbs2-0057,
CD008018-bib-0060,M Karimi-Zarchi. ,Additional data [personal communication],,,,. Email to: M. Karimi-Zarchi 8 December 2018.   ,['citation-other'], M Karimi-Zarchi. Additional data [personal communication]. Email to: M. Karimi-Zarchi 8 December 2018.    ,[],,, Karimi‐Zarchi 2014 [pers comm] ,additional,CD008018-bbs2-0058,
CD008018-bib-0061,Lucia Del Mastro. ,Additional data [personal communication],,,,. Email to: Lucia Del Mastro 15 September 2018.   ,['citation-other'], Lucia Del Mastro. Additional data [personal communication]. Email to: Lucia Del Mastro 15 September 2018.    ,[],,, Lambertini 2015 [pers comm] ,additional,CD008018-bbs2-0059,
CD008018-bib-0062,"Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, et al. ",Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies, Annals of Oncology ,2015,51,    ,['citation-journal']," Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.  Annals of Oncology 2015;51(12):S318-S319.    Link to article     Google Scholar     ","['https://doi.org/10.1093/annonc/mdv374', 'https://scholar.google.com/scholar_lookup?title=Ovarian+suppression+using+luteinizing+hormone-releasing+hormone+agonists+during+chemotherapy+to+preserve+ovarian+function+and+fertility+of+breast+cancer+patients:+a+meta-analysis+of+randomized+studies+&author=M+Lambertini&author=M+Ceppi&author=F+Poggio&author=FA+Peccatori&author=HA+Azim&author=D+Ugolini&publication_year=2015&hl=en']",,https://doi.org/10.1093/annonc/mdv374, Lambertini 2015b ,additional,CD008018-bbs2-0060,
CD008018-bib-0063,"Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim HA Jr, Peccatori FA, et al. ",Cancer and fertility preservation: international recommendations from an expert meeting, BMC Medicine ,2016,14,    ,['citation-journal']," Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim HA Jr, Peccatori FA, et al. Cancer and fertility preservation: international recommendations from an expert meeting.  BMC Medicine 2016;14:1.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1186/s12916-015-0545-7', 'https://www.ncbi.nlm.nih.gov/pubmed/26728489', 'https://scholar.google.com/scholar_lookup?title=Cancer+and+fertility+preservation:+international+recommendations+from+an+expert+meeting&author=M+Lambertini&author=L+DelMastro&author=MC+Pescio&author=CY+Andersen&author=FA+Peccatori&publication_year=2016&hl=en']",26728489,https://doi.org/10.1186/s12916-015-0545-7, Lambertini 2016 ,additional,CD008018-bbs2-0061,
CD008018-bib-0064,Robert C F Leonard. ,Additional or missing data [personal communication],,,,. Email to: Robert C. F. Leonard 26 November 2018.   ,['citation-other'], Robert C F Leonard. Additional or missing data [personal communication]. Email to: Robert C. F. Leonard 26 November 2018.    ,[],,, Leonard 2017 [pers comm] ,additional,CD008018-bbs2-0062,
CD008018-bib-0065,"Levine JM, Kelvin JF, Quinn GP, Gracia CR. ",Infertility in reproductive-age female cancer survivors, Cancer ,2015,121,    ,['citation-journal']," Levine JM, Kelvin JF, Quinn GP, Gracia CR. Infertility in reproductive-age female cancer survivors.  Cancer 2015;121(10):1532-9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/cncr.29181', 'https://www.ncbi.nlm.nih.gov/pubmed/25649243', 'https://scholar.google.com/scholar_lookup?title=Infertility+in+reproductive-age+female+cancer+survivors&author=JM+Levine&author=JF+Kelvin&author=GP+Quinn&author=CR+Gracia&publication_year=2015&hl=en']",25649243,https://doi.org/10.1002/cncr.29181, Levine 2015 ,additional,CD008018-bbs2-0063,
CD008018-bib-0066,"Li X, Kang X, Deng Q, Cai J, Wang Z. ",Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study, Reproductive Biology and Endocrinology ,2013,11,    ,['citation-journal']," Li X, Kang X, Deng Q, Cai J, Wang Z. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.  Reproductive Biology and Endocrinology 2013;11:16. [DOI: 10.1186/1477-7827-11-16]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1186/1477-7827-11-16', 'https://www.ncbi.nlm.nih.gov/pubmed/23452939', 'https://scholar.google.com/scholar_lookup?title=Combination+of+a+GnRH+agonist+with+an+antagonist+prevents+flare-up+effects+and+protects+primordial+ovarian+follicles+in+the+rat+ovary+from+cisplatin-induced+toxicity:+a+controlled+experimental+animal+study+&author=X+Li&author=X+Kang&author=Q+Deng&author=J+Cai&author=Z+Wang&publication_year=2013&hl=en']",23452939,https://doi.org/10.1186/1477-7827-11-16, Li 2013 ,additional,CD008018-bbs2-0064,
CD008018-bib-0067,"Luborsky J, Llanes B, Roussev R, Coulam C. ","Ovarian antibodies, FSH and inhibin B: Independent markers associated with unexplained infertility", Human Reproduction ,2000,15,    ,['citation-journal']," Luborsky J, Llanes B, Roussev R, Coulam C. Ovarian antibodies, FSH and inhibin B: Independent markers associated with unexplained infertility.  Human Reproduction 2000;15(5):1046-51.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humrep/15.5.1046', 'https://www.ncbi.nlm.nih.gov/pubmed/10783349', 'https://scholar.google.com/scholar_lookup?title=Ovarian+antibodies,+FSH+and+inhibin+B:+Independent+markers+associated+with+unexplained+infertility+&author=J+Luborsky&author=B+Llanes&author=R+Roussev&author=C+Coulam&publication_year=2000&hl=en']",10783349,https://doi.org/10.1093/humrep/15.5.1046, Luborsky 2000 ,additional,CD008018-bbs2-0065,
CD008018-bib-0068,"Lutchman Singh K, Davies M, Chatterjee R. ","Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing", Human Reproduction Update ,2005,11,    ,['citation-journal']," Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.  Human Reproduction Update 2005;11:69–89.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humupd/dmh052', 'https://www.ncbi.nlm.nih.gov/pubmed/15569700', 'https://scholar.google.com/scholar_lookup?title=Fertility+in+female+cancer+survivors:+pathophysiology,+preservation+and+the+role+of+ovarian+reserve+testing+&author=K+LutchmanSingh&author=M+Davies&author=R+Chatterjee&publication_year=2005&hl=en']",15569700,https://doi.org/10.1093/humupd/dmh052, Lutchman‐Singh 2005 ,additional,CD008018-bbs2-0066,
CD008018-bib-0069,"Maggi R, Cariboni AM, Marelli MM, Moretti RM, Andrè V, Marzagalli M, et al. ",GnRH and GnRH receptors in the pathophysiology of the human female reproductive system, Human Reproduction Update ,2016,22,    ,['citation-journal']," Maggi R, Cariboni AM, Marelli MM, Moretti RM, Andrè V, Marzagalli M, et al. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.  Human Reproduction Update 2016;22(3):358-81.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humupd/dmv059', 'https://www.ncbi.nlm.nih.gov/pubmed/26715597', 'https://scholar.google.com/scholar_lookup?title=GnRH+and+GnRH+receptors+in+the+pathophysiology+of+the+human+female+reproductive+system&author=R+Maggi&author=AM+Cariboni&author=MM+Marelli&author=RM+Moretti&author=V+Andrè&author=M+Marzagalli&publication_year=2016&hl=en']",26715597,https://doi.org/10.1093/humupd/dmv059, Maggi 2016 ,additional,CD008018-bbs2-0067,
CD008018-bib-0070,"Meirow D, Assad G, Dor J, Rabinovici J. ",The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice, Human Reproduction ,2004,19,    ,['citation-journal']," Meirow D, Assad G, Dor J, Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice.  Human Reproduction 2004;19(6):1294-9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humrep/deh257', 'https://www.ncbi.nlm.nih.gov/pubmed/15117898', 'https://scholar.google.com/scholar_lookup?title=The+GnRH+antagonist+cetrorelix+reduces+cyclophosphamide-induced+ovarian+follicular+destruction+in+mice+&author=D+Meirow&author=G+Assad&author=J+Dor&author=J+Rabinovici&publication_year=2004&hl=en']",15117898,https://doi.org/10.1093/humrep/deh257, Meirow 2004 ,additional,CD008018-bbs2-0068,
CD008018-bib-0071,Halle CF Moore. ,Additional or missing data [personal communication],,,,. Email to: Halle C.F. Moore 21 May 2018.   ,['citation-other'], Halle CF Moore. Additional or missing data [personal communication]. Email to: Halle C.F. Moore 21 May 2018.    ,[],,, Moore 2015 [pers comm] ,additional,CD008018-bbs2-0069,
CD008018-bib-0072,"Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. ",How do chemotherapeutic agents damage the ovary, Human Reproduction Update ,2012,18,    ,['citation-journal']," Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary.  Human Reproduction Update 2012;18(5):525-35.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humupd/dms022', 'https://www.ncbi.nlm.nih.gov/pubmed/22647504', 'https://scholar.google.com/scholar_lookup?title=How+do+chemotherapeutic+agents+damage+the+ovary&author=S+Morgan&author=RA+Anderson&author=C+Gourley&author=WH+Wallace&author=N+Spears&publication_year=2012&hl=en']",22647504,https://doi.org/10.1093/humupd/dms022, Morgan 2012 ,additional,CD008018-bbs2-0070,
CD008018-bib-0073,"Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al. ",Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis, JAMA Oncology ,2016,2,    ,['citation-journal']," Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al. Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis.  JAMA Oncology 2016;2(1):65-73.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/jamaoncol.2015.3251', 'https://www.ncbi.nlm.nih.gov/pubmed/26426573', 'https://scholar.google.com/scholar_lookup?title=Gonadotropin-releasing+hormone+agonists+for+ovarian+function+preservation+in+premenopausal+women+undergoing+chemotherapy+for+early-stage+breast+cancer:+a+systematic+review+and+meta-analysis+&author=RR+Munhoz&author=AA+Pereira&author=AD+Sasse&author=PM+Hoff&author=TA+Traina&author=CA+Hudis&publication_year=2016&hl=en']",26426573,https://doi.org/10.1001/jamaoncol.2015.3251, Munhoz 2016 ,additional,CD008018-bbs2-0071,
CD008018-bib-0074,Pamela N Munster. ,Additional or missing data [personal communication],,,,. Email to: Pamela N. Munster 15 September 2018.   ,['citation-other'], Pamela N Munster. Additional or missing data [personal communication]. Email to: Pamela N. Munster 15 September 2018.    ,[],,, Munster 2012 [pers comm] ,additional,CD008018-bbs2-0072,
CD008018-bib-0075,"Peng P, Yang DZ, Zheng CY, Mo YQ, He YM, Zhang QX. ",Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats, Zhonghua Fu Chan Ke Za Zhi ,2007,42,    ,['citation-journal']," Peng P, Yang DZ, Zheng CY, Mo YQ, He YM, Zhang QX. Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats.  Zhonghua Fu Chan Ke Za Zhi 2007;42:546-50.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/17983495', 'https://scholar.google.com/scholar_lookup?title=Effects+of+gonadotropin+releasing+hormone+analogues+on+chemotherapy-induced+ovarian+function+damage+in+rats+&author=P+Peng&author=DZ+Yang&author=CY+Zheng&author=YQ+Mo&author=YM+He&author=QX+Zhang&publication_year=2007&hl=en']",17983495,, Peng 2007 ,additional,CD008018-bbs2-0073,
CD008018-bib-0076,"Nordic Cochrane Centre, The Cochrane Collaboration",Review Manager 5 (RevMan 5),,2014,,.   ,['citation-other']," Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.    ",[],,, Review Manager 2014 [Computer program] ,additional,CD008018-bbs2-0074,
CD008018-bib-0077,"Shelling AN, Burton KA, Chand AL, Van Ee CC, France JT, Farquhar CM, et al. ",Inhibin: a candidate gene for premature ovarian failure, Human Reproduction ,2000,15,    ,['citation-journal']," Shelling AN, Burton KA, Chand AL, Van Ee CC, France JT, Farquhar CM, et al. Inhibin: a candidate gene for premature ovarian failure.  Human Reproduction 2000;15(12):2644-9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/humrep/15.12.2644', 'https://www.ncbi.nlm.nih.gov/pubmed/11098038', 'https://scholar.google.com/scholar_lookup?title=Inhibin:+a+candidate+gene+for+premature+ovarian+failure&author=AN+Shelling&author=KA+Burton&author=AL+Chand&author=CC+VanEe&author=JT+France&author=CM+Farquhar&publication_year=2000&hl=en']",11098038,https://doi.org/10.1093/humrep/15.12.2644, Shelling 2000 ,additional,CD008018-bbs2-0075,
CD008018-bib-0078,"Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. ",Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise, Aging (Albany NY) ,2011,3,    ,['citation-journal']," Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.  Aging (Albany NY) 2011;3(8):782-93.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.18632/aging.100363', 'https://www.ncbi.nlm.nih.gov/pubmed/21869459', 'https://scholar.google.com/scholar_lookup?title=Mechanisms+of+chemotherapy-induced+human+ovarian+aging:+double+strand+DNA+breaks+and+microvascular+compromise+&author=R+Soleimani&author=E+Heytens&author=Z+Darzynkiewicz&author=K+Oktay&publication_year=2011&hl=en']",21869459,https://doi.org/10.18632/aging.100363, Soleimani 2011 ,additional,CD008018-bbs2-0076,
CD008018-bib-0079,Guiping Song. ,Additional data [personal communication],,,,. Email to: Guiping Song 15 September 2018.   ,['citation-other'], Guiping Song. Additional data [personal communication]. Email to: Guiping Song 15 September 2018.    ,[],,, Song 2013 [pers comm] ,additional,CD008018-bbs2-0077,
CD008018-bib-0080,"Tan SJ, Lee LJ, Tzeng CR, Wang CW, Hsu MI, Chen CH. ",Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity, Reproductive Biomedicine Online ,2014,29,    ,['citation-journal']," Tan SJ, Lee LJ, Tzeng CR, Wang CW, Hsu MI, Chen CH. Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity.  Reproductive Biomedicine Online 2014;29(5):612-20.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.rbmo.2014.07.014', 'https://www.ncbi.nlm.nih.gov/pubmed/25246113', 'https://scholar.google.com/scholar_lookup?title=Targeted+anti-apoptosis+activity+for+ovarian+protection+against+chemotherapy-induced+ovarian+gonadotoxicity+&author=SJ+Tan&author=LJ+Lee&author=CR+Tzeng&author=CW+Wang&author=MI+Hsu&author=CH+Chen&publication_year=2014&hl=en']",25246113,https://doi.org/10.1016/j.rbmo.2014.07.014, Tan 2014 ,additional,CD008018-bbs2-0078,
CD008018-bib-0081,"Trivers KF, Fink AK, Partridge AH, Oktay K, Ginsburg ES, Li C, et al. ",Estimates of young breast cancer survivors at risk for infertility in the U.S, Oncologist ,2014,19,    ,['citation-journal']," Trivers KF, Fink AK, Partridge AH, Oktay K, Ginsburg ES, Li C, et al. Estimates of young breast cancer survivors at risk for infertility in the U.S.  Oncologist 2014;19(8):814-22.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1634/theoncologist.2014-0016', 'https://www.ncbi.nlm.nih.gov/pubmed/24951610', 'https://scholar.google.com/scholar_lookup?title=Estimates+of+young+breast+cancer+survivors+at+risk+for+infertility+in+the+U.S&author=KF+Trivers&author=AK+Fink&author=AH+Partridge&author=K+Oktay&author=ES+Ginsburg&author=C+Li&publication_year=2014&hl=en']",24951610,https://doi.org/10.1634/theoncologist.2014-0016, Trivers 2014 ,additional,CD008018-bbs2-0079,
CD008018-bib-0021,"Anderson R, Yellowlees A, Dunlop J, Thomas G, Leonard R. ",Administration of a GnRH agonist during chemotherapy for breast cancer reduces ovarian toxicity in women aged under 40 years,,2016,,    ,['citation-other']," Anderson R, Yellowlees A, Dunlop J, Thomas G, Leonard R. Administration of a GnRH agonist during chemotherapy for breast cancer reduces ovarian toxicity in women aged under 40 years. In: Human Reproduction (Oxford, England). Vol. 31. 2016:suppl 1.1. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Administration+of+a+GnRH+agonist+during+chemotherapy+for+breast+cancer+reduces+ovarian+toxicity+in+women+aged+under+40+years+&author=R+Anderson&author=A+Yellowlees&author=J+Dunlop&author=G+Thomas&author=R+Leonard&publication_year=2016&hl=en']",,, Anderson 2016 {published data only}  ,awaiting_assessment,CD008018-bbs2-0019,
CD008018-bib-0022,"Behringer K, Wildt L, Haverkamp H, Diehl V, Pfistner B, Engert A. ",Results of the randomised phase II for the reduction of ovarian failure with use GnRH-analogues and oral contraceptives in young women (18-40 years) treated with intensive chemotherapy for advanced-stage Hodgkin lymphoma (HL),,2007,,    ,['citation-other']," Behringer K, Wildt L, Haverkamp H, Diehl V, Pfistner B, Engert A. Results of the randomised phase II for the reduction of ovarian failure with use GnRH-analogues and oral contraceptives in young women (18-40 years) treated with intensive chemotherapy for advanced-stage Hodgkin lymphoma (HL). In: Haematologia. Vol. 92 Suppl 5. 2007:63-4. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Results+of+the+randomised+phase+II+for+the+reduction+of+ovarian+failure+with+use+GnRH-analogues+and+oral+contraceptives+in+young+women+(18-40+years)+treated+with+intensive+chemotherapy+for+advanced-stage+Hodgkin+lymphoma+(HL)+&author=K+Behringer&author=L+Wildt&author=H+Haverkamp&author=V+Diehl&author=B+Pfistner&author=A+Engert&publication_year=2007&hl=en']",,, Behringer 2007 {published data only}  ,awaiting_assessment,CD008018-bbs2-0020,
CD008018-bib-0023,"Ismail-Khan R, Minton S, Cox C, Sims I, Lacevic M, Gross-King M, et al. ",Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using the GnRH agonist (triptorelin) during chemotherapy,,2008,,    ,['citation-other']," Ismail-Khan R, Minton S, Cox C, Sims I, Lacevic M, Gross-King M, et al. Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using the GnRH agonist (triptorelin) during chemotherapy. In: Journal of Clinical Oncology: ASCO annual meeting proceedings. Vol. 26. 2008:12. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Preservation+of+ovarian+function+in+young+women+treated+with+neoadjuvant+chemotherapy+for+breast+cancer:+a+randomized+trial+using+the+GnRH+agonist+(triptorelin)+during+chemotherapy+&author=R+Ismail-Khan&author=S+Minton&author=C+Cox&author=I+Sims&author=M+Lacevic&author=M+Gross-King&publication_year=2008&hl=en']",,, Ismail‐Khan 2008 {published data only}  ,awaiting_assessment,CD008018-bbs2-0021,
CD008018-bib-0024,"Karimi-Zarchi M, Forat-Yazdi M, Nakhaie-Moghadam M. ",Ovarian function preservation by GnRH agonists during chemotherapy in Hodgkin lymphoma patients- a double blind randomized control trial clinical,,2011,,    ,['citation-other']," Karimi-Zarchi M, Forat-Yazdi M, Nakhaie-Moghadam M. Ovarian function preservation by GnRH agonists during chemotherapy in Hodgkin lymphoma patients- a double blind randomized control trial clinical. In: International Journal of Gynecological Cancer. Vol. 21. 2011:Suppl 3. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Ovarian+function+preservation+by+GnRH+agonists+during+chemotherapy+in+Hodgkin+lymphoma+patients-+a+double+blind+randomized+control+trial+clinical+&author=M+Karimi-Zarchi&author=M+Forat-Yazdi&author=M+Nakhaie-Moghadam&publication_year=2011&hl=en']",,, Karimi‐Zarchi 2011 {published data only}  ,awaiting_assessment,CD008018-bbs2-0022,
CD008018-bib-0025,"Rossi G, Iadarola R, Lambertini M, Poggio F, Levaggi A, Bighin C, et al. ",The value of hormone serum concentration to predict the gonadotoxic effect of chemotherapy and the efficacy of LHRH analogs as a strategy to reduce treatment-related premature ovarian failure in breast cancer,,2015,,    ,['citation-other']," Rossi G, Iadarola R, Lambertini M, Poggio F, Levaggi A, Bighin C, et al. The value of hormone serum concentration to predict the gonadotoxic effect of chemotherapy and the efficacy of LHRH analogs as a strategy to reduce treatment-related premature ovarian failure in breast cancer. In: Annals of Oncology. Vol. 26 Supp 6. 2015:vi3–vi25. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+value+of+hormone+serum+concentration+to+predict+the+gonadotoxic+effect+of+chemotherapy+and+the+efficacy+of+LHRH+analogs+as+a+strategy+to+reduce+treatment-related+premature+ovarian+failure+in+breast+cancer+&author=G+Rossi&author=R+Iadarola&author=M+Lambertini&author=F+Poggio&author=A+Levaggi&author=C+Bighin&publication_year=2015&hl=en']",,, Rossi 2015 {published data only}  ,awaiting_assessment,CD008018-bbs2-0023,
CD008018-bib-0082,"Chen H, Lina H. ",Adjuvant gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal women, Cochrane Database of Systematic Reviews ,2009,,    ,['citation-journal']," Chen H, Lina H. Adjuvant gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal women.  Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No: CD008018. [DOI: 10.1002/14651858.CD008018]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD008018', 'https://scholar.google.com/scholar_lookup?title=Adjuvant+gonadotropin-releasing+hormone+analogues+for+chemotherapy+induced+premature+ovarian+failure+in+premenopausal+women+&author=H+Chen&author=H+Lina&publication_year=2009&hl=en']",,https://doi.org/10.1002/14651858.CD008018, Chen 2009 ,other_versions,CD008018-bbs2-0080,
CD008018-bib-0083,"Chen H, Li J, Cui T, Hu L. ",Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women, Cochrane Database of Systematic Reviews ,2011,,    ,['citation-journal']," Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women.  Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No: CD008018. [DOI: 10.1002/14651858.CD008018.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD008018.pub2', 'https://scholar.google.com/scholar_lookup?title=Adjuvant+gonadotropin-releasing+hormone+analogues+for+the+prevention+of+chemotherapy+induced+premature+ovarian+failure+in+premenopausal+women+&author=H+Chen&author=J+Li&author=T+Cui&author=L+Hu&publication_year=2011&hl=en']",,https://doi.org/10.1002/14651858.CD008018.pub2, Chen 2011 ,other_versions,CD008018-bbs2-0081,
